Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBD effects on opioid plasma levels in chronic radiculopathy
NCT04760613Phase 2Completed
- Sponsor
- NYU Langone Health
- Start
- Feb 2022
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cannabidiol in radiculopathy, sponsored by NYU Langone Health. Started Feb 2022; status: completed.
02
Drugs
cannabidiol
03
Conditions
radiculopathy
Beyond the preview
Go deeper on NCT04760613.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04760613.